Leiomyoma of the prostate: A case report and literature review.

IF 1.3 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL
Zejun Liu, Ji Lu, Kai Yu, Tengteng Jian, Rui Hu, Min Liu
{"title":"Leiomyoma of the prostate: A case report and literature review.","authors":"Zejun Liu, Ji Lu, Kai Yu, Tengteng Jian, Rui Hu, Min Liu","doi":"10.1097/MD.0000000000040340","DOIUrl":null,"url":null,"abstract":"<p><strong>Rationale: </strong>Prostate leiomyoma is a rare condition globally, often challenging to diagnose preoperatively, with most cases being definitively identified through postoperative pathology. This benign tumor generally has a good prognosis and is primarily treated with transurethral resection of the prostate in clinical settings. However, there are no established guidelines or therapeutic protocols for managing this disease.</p><p><strong>Patient concerns: </strong>The patient was admitted to our hospital's Department of Urology with complaints of hematuria, urinary frequency, and urgency for 1 month. Pelvic computed tomography revealed an irregular, mass-like high-density shadow posterior to the bladder, indistinctly separated from the prostate. The patient had been diagnosed with renal insufficiency during a physical examination 4 years prior but had not received standardized treatment. Six years ago, the patient underwent electrocision of the prostate at our hospital, and postoperative pathology indicated prostate leiomyoma.</p><p><strong>Diagnoses: </strong>Postoperative pathology confirmed a diagnosis of prostate leiomyoma.</p><p><strong>Interventions: </strong>The patient presented with an enlarged prostate and preoperative hematuria. Holmium laser enucleation of the prostate (HoLEP) was performed. The Foley catheter was removed on the second postoperative day, and the patient was discharged 3 days after surgery.</p><p><strong>Outcomes: </strong>Following discharge, the patient was instructed to undergo reexaminations every 6 months. Current follow-up indicates the patient is in good health, with no recurrence of the mass observed.</p><p><strong>Lessons: </strong>Prostate leiomyoma is an extremely rare condition, and the current primary approach for managing prostate smooth muscle tumors involves active patient monitoring, regular evaluations, and timely surgical intervention if clinical symptoms emerge. In this study, we present a new case report of prostatic smooth muscle tumor and review the existing literature to explore treatment options for prostate leiomyoma within this field.</p>","PeriodicalId":18549,"journal":{"name":"Medicine","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11537628/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MD.0000000000040340","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Rationale: Prostate leiomyoma is a rare condition globally, often challenging to diagnose preoperatively, with most cases being definitively identified through postoperative pathology. This benign tumor generally has a good prognosis and is primarily treated with transurethral resection of the prostate in clinical settings. However, there are no established guidelines or therapeutic protocols for managing this disease.

Patient concerns: The patient was admitted to our hospital's Department of Urology with complaints of hematuria, urinary frequency, and urgency for 1 month. Pelvic computed tomography revealed an irregular, mass-like high-density shadow posterior to the bladder, indistinctly separated from the prostate. The patient had been diagnosed with renal insufficiency during a physical examination 4 years prior but had not received standardized treatment. Six years ago, the patient underwent electrocision of the prostate at our hospital, and postoperative pathology indicated prostate leiomyoma.

Diagnoses: Postoperative pathology confirmed a diagnosis of prostate leiomyoma.

Interventions: The patient presented with an enlarged prostate and preoperative hematuria. Holmium laser enucleation of the prostate (HoLEP) was performed. The Foley catheter was removed on the second postoperative day, and the patient was discharged 3 days after surgery.

Outcomes: Following discharge, the patient was instructed to undergo reexaminations every 6 months. Current follow-up indicates the patient is in good health, with no recurrence of the mass observed.

Lessons: Prostate leiomyoma is an extremely rare condition, and the current primary approach for managing prostate smooth muscle tumors involves active patient monitoring, regular evaluations, and timely surgical intervention if clinical symptoms emerge. In this study, we present a new case report of prostatic smooth muscle tumor and review the existing literature to explore treatment options for prostate leiomyoma within this field.

前列腺 Leiomyoma:病例报告和文献综述
理论依据:前列腺良性肌瘤是一种全球罕见的疾病,通常很难在术前确诊,大多数病例要通过术后病理才能明确诊断。这种良性肿瘤一般预后良好,临床上主要采用经尿道前列腺切除术治疗。然而,目前还没有治疗这种疾病的既定指南或治疗方案:患者因主诉血尿、尿频和尿急 1 个月而入住我院泌尿科。盆腔计算机断层扫描显示,膀胱后方有一个不规则的肿块状高密度阴影,与前列腺分界不清。患者在 4 年前的体检中被诊断为肾功能不全,但未接受规范治疗。六年前,患者在我院接受了前列腺电切术,术后病理结果显示为前列腺良性肌瘤:术后病理确诊为前列腺细肌瘤:患者出现前列腺增大和术前血尿。进行了前列腺钬激光去核术(HoLEP)。术后第二天拔除福里导尿管,术后 3 天出院:出院后,医生嘱咐患者每 6 个月复查一次。目前的随访显示患者健康状况良好,未发现肿块复发:前列腺平滑肌瘤是一种极为罕见的疾病,目前治疗前列腺平滑肌瘤的主要方法包括积极监测患者、定期评估以及在出现临床症状时及时进行手术干预。在本研究中,我们报告了一例新的前列腺平滑肌瘤病例,并回顾了现有文献,探讨了该领域中前列腺良性肌瘤的治疗方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Medicine
Medicine 医学-医学:内科
CiteScore
2.80
自引率
0.00%
发文量
4342
审稿时长
>12 weeks
期刊介绍: Medicine is now a fully open access journal, providing authors with a distinctive new service offering continuous publication of original research across a broad spectrum of medical scientific disciplines and sub-specialties. As an open access title, Medicine will continue to provide authors with an established, trusted platform for the publication of their work. To ensure the ongoing quality of Medicine’s content, the peer-review process will only accept content that is scientifically, technically and ethically sound, and in compliance with standard reporting guidelines.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信